Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Smitha Menon"'
Autor:
Bicky Thapa, Gulrayz Ahmed, Aniko Szabo, Mandana Kamgar, Deepak Kilari, Maahum Mehdi, Smitha Menon, Sherin Daniel, Jonathan Thompson, James Thomas, Ben George
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
PurposeThere is variability in utilization of Comprehensive Genomic Profiling (CGP) in most of the metastatic solid tumors (MST). We evaluated the CGP utilization patterns and its impact on outcomes at an academic tertiary center.Patients and Methods
Externí odkaz:
https://doaj.org/article/80abdc4e195d4f0eb41ebce78e03294d
Publikováno v:
Cancers, Vol 8, Iss 12, p 106 (2016)
Immunotherapy is heralded as one of the most important advances in oncology. Until recently, only limited immunotherapeutic options were available in selected immunogenic cancers like melanoma and renal cell carcinomas. Nowadays, there is an improved
Externí odkaz:
https://doaj.org/article/4d4f9b2cee1e4b15965350fe01f62dc5
Autor:
Satish Ramanathan, Micheal Sunny, Smitha Menon, Srinivas Chakravarthy, Thirumalai Nallathambi
Publikováno v:
Indian journal of Medical Biochemistry. 22:1-5
Autor:
Satish Ramanathan, Mathivanan Durairaj, Smitha Menon, Jayarani Arokia, Vijayakumar Valappil, Srinivas Chakravarthy
Publikováno v:
Indian Journal of Clinical Biochemistry. 33:113-116
Paraproteinemia is characterised by clonal proliferation of plasma cells. A common laboratory finding in paraproteinemia being a monoclonal peak in serum protein electrophoresis (M band). But there are factors which produce a peak similar to M spike
Autor:
Jennifer Johnson, S. Poudel, Massimo Cristofanilli, Martin Gutierrez, J. Doudement, Gaurav Singal, Stefan C. Grant, C. Ellis, V.A. Miller, John Douglas Mcpherson, Aniko Szabo, Ben George, Lindsay Chan, Smitha Menon, Brian M. Alexander, W. Kevin Kelly, Davendra Sohal, Christopher J. Hoimes
Publikováno v:
Journal of Thoracic Oncology. 15:S29-S30
Autor:
Kiefer Haug, Kaitlyn Bartow, Smitha Menon, Hasan Samra, Huiya Huang, Stephanie Springborn, Alexander C. Mackinnon
Publikováno v:
The Journal of molecular diagnostics : JMD. 21(5)
The Idylla Mutation Test System is an automated, PCR-based mutation testing system. The advantages of this system can greatly impact the delivery of precision medicine. We describe our evaluation, validation, and implementation of this system for rou
Autor:
Aminah Jatoi, Smitha Menon, Jennifer Le-Rademacher, Donald J. Tindall, Carmen Radecki Breitkopf, Lucy J. Schmidt, Christopher S R Dakhil, Kendrith M. Rowland, Zhifu Sun, Mark R. Pittelkow, Pamela J. Atherton, Angelina Tan, Phuong L. Nguyen
Publikováno v:
The American journal of hospicepalliative care. 36(6)
Background: Although 50% to 90% of patients who receive epidermal growth factor receptor (EGFR) inhibitors develop a rash, options for rash prevention or palliation remain limited. This issue is particularly important from a palliative care standpoin
Autor:
Claire Griffiths, Smitha Menon
Publikováno v:
Precision Cancer Medicine. 3:33-33
Autor:
Ashish Saxena, Smitha Menon, Alice T. Shaw, Adam J. Schoenfeld, Jochen K. Lennerz, Jessica J. Lin, Anna F. Farago, Angela Taber, Ibiayi Dagogo-Jack, Anne M. Traynor, Gregory J. Riely, Viola W. Zhu, Justin F. Gainor, Sai-Hong Ignatius Ou, Beow Y. Yeap, Lorin A. Ferris, Subba R. Digumarthy, Andrew J. Plodkowski
BACKGROUND: The second-generation ALK inhibitor alectinib recently demonstrated superior efficacy compared to the first-generation ALK inhibitor crizotinib in advanced anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer (NSCLC), es
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5223cc6ac7a83bbba2b0055adcb85b7
https://europepmc.org/articles/PMC6341982/
https://europepmc.org/articles/PMC6341982/
Autor:
Smitha Menon, Aminah Jatoi
Publikováno v:
Lung Cancer Management. 3:411-416
SUMMARY Most lung cancer patients in the USA are older than 65 years of age, and yet oncologists continue to struggle with how best to treat these older patients. This article reviews the medical management of non-small-cell lung cancer in older pati